Application segmentation of the Boron Chloride market delineates four primary end‑use categories. Pharmaceuticals account for the largest share, roughly 35 % of total revenue, driven by the compound’s role as a Lewis acid catalyst in the synthesis of active pharmaceutical ingredients. Chemical synthesis follows with an estimated 30 % contribution, reflecting demand from petrochemical intermediates, polymer additives, and specialty chemicals where Boron Chloride facilitates chlorination and dehydration reactions. The electronics segment, representing about 20 % of the market, is anchored in the production of semiconductor etchants and thin‑film deposition processes that require high‑purity, anhydrous material. Finally, metal processing comprises approximately 15 % of sales, used in surface treatment and alloy modification where its corrosive properties enable precise etching. Collectively, these applications define the market taxonomy and illustrate how each sub‑segment’s growth dynamics feed into the overall Boron Chloride market size, a key focus of Boron Chloride segmentation analysis. These proportions also guide strategic investment decisions, as firms prioritize R&D and capacity expansion aligned with the dominant pharmaceutical and chemical synthesis demand.